Toxoplasmosis in Cats: Zoonotic Risk and Pregnancy Guidelines
Etiology and Life Cycle
Toxoplasmosis is caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. Felids, including domestic cats (Felis catus), serve as the definitive hosts in which the parasite completes its sexual cycle and produces environmentally resistant oocysts [1, 2]. The life cycle involves both asexual replication in intermediate hosts (including mammals and birds) and sexual replication exclusively within the feline intestinal epithelium [1, 2]. After ingestion of tissue cysts from infected prey or contaminated meat, the parasite undergoes a complex developmental program in the feline gut. A single-cell atlas of sexual development in the feline intestinal tract has revealed the transcriptional dynamics of merozoite, gametocyte, and oocyst formation [2]. The pre-sexual stages proliferate through endodyogeny and schizogony before committing to gametogenesis [1]. Oocysts are shed in feces, sporulate in the environment, and become infectious to a wide range of warm-blooded animals [3, 4].
Epidemiology and Seroprevalence
T. gondii infection is distributed globally, with seroprevalence rates varying by geographic region, management practices, and host species [5, 4, 6]. In privately-owned cats and community cats in Hong Kong, seroprevalence was associated with demographic factors such as age, outdoor access, and diet [5]. A study in Jordan reported the first seroprevalence and molecular detection of toxoplasmosis in cats, identifying raw meat feeding and stray status as significant risk factors [4]. In urban informal settlements in Salvador, Brazil, seroprevalence in companion animals, including cats, was linked to environmental degradation and social marginalization [6]. Similar patterns of high seroprevalence have been documented in wild felids in Poland, indicating widespread environmental contamination [7]. The seroprevalence of T. gondii in cats is influenced by hunting behavior, exposure to contaminated soil, and the density of rodent intermediate hosts [5, 4, 6].
Clinical Signs and Pathology in Cats
Most immunocompetent cats infected with T. gondii remain asymptomatic [8, 9]. Clinical disease is more common in kittens, immunosuppressed cats, or those co-infected with other pathogens. The AB blood group system phenotype does not play a role in susceptibility to T. gondii infection in cats [9]. When clinical signs occur, they may include fever, lethargy, anorexia, dyspnea, ocular inflammation (uveitis, chorioretinitis), and neurological deficits such as ataxia, seizures, or cranial nerve abnormalities [8, 10]. The parasite can alter host behavior; infected rodents exhibit reduced aversion to feline odors, a phenomenon that enhances predation risk and facilitates transmission to the definitive host [10]. In cats, the entero-epithelial stage can be detected using markers such as MIC17A, which is expressed during both entero-epithelial and chronic stages [8]. Histopathological lesions include necrotizing enteritis, hepatitis, pneumonitis, and encephalitis, with intralesional tachyzoites or tissue cysts [8, 11].
Zoonotic Risk and Cat Toxoplasmosis Baby Concerns
The primary zoonotic concern associated with feline toxoplasmosis is the risk of primary maternal infection during pregnancy, which can lead to congenital transmission and fetal pathology [12, 13, 14]. The term "cat toxoplasmosis baby" refers to the potential for vertical transmission of T. gondii from a pregnant woman to her fetus following acute infection acquired from oocyst-contaminated environments [12, 14]. Cats shed oocysts for a limited period (1-3 weeks) after primary infection, and these oocysts must sporulate in the environment for 1-5 days before becoming infectious [3, 14]. Direct contact with a cat is not the primary risk; rather, the risk arises from handling contaminated litter boxes, gardening in soil where cats have defecated, or consuming unwashed vegetables [13, 14]. Studies on knowledge and practices among pregnant women in Abidjan, Côte d'Ivoire, revealed significant gaps in awareness of toxoplasmosis transmission routes [13]. In Kars, Turkey, anti-T. gondii antibody seropositivity was investigated in women with a history of abortion or stillbirth, highlighting the reproductive consequences of infection [12]. French guidelines emphasize that seronegative pregnant women should avoid handling cat litter or wear gloves and wash hands thoroughly if contact is unavoidable [14].
Pathogenesis and Host-Parasite Interactions
After ingestion, sporozoites or bradyzoites penetrate the intestinal epithelium and differentiate into rapidly dividing tachyzoites [1, 2]. Tachyzoites disseminate via the bloodstream and lymphatics to invade nucleated cells in multiple tissues, including the brain, retina, skeletal muscle, and placenta [8, 15]. The host immune response, particularly interferon-gamma (IFN-γ) mediated by T cells, controls tachyzoite proliferation and induces conversion to the slow-growing bradyzoite stage within tissue cysts [16, 17]. In the feline small intestine, dynamic changes in microRNA expression occur during infection, regulating host immune responses and parasite development [18]. The parasite's ability to manipulate host cell signaling and evade immune destruction is central to its persistence [16, 17]. Gene-edited live-attenuated vaccines have been developed to target key virulence factors, aiming to induce protective immunity without causing disease [16]. Advances in antigen discovery, including mRNA-based strategies, are being explored under a One Health framework [17].
Diagnostic Approaches
Diagnosis of feline toxoplasmosis relies on a combination of serological, molecular, and histopathological methods [19, 20, 8, 21]. Serological detection of anti-T. gondii antibodies (IgG and IgM) is the most common approach. Commercial ELISA kits and double-antigen sandwich colloidal gold immunochromatographic strips have been developed for rapid serological screening in multiple host species, including cats [19, 20]. The SAG1-based immunochromatographic strip offers a rapid, point-of-care option for detecting antibodies in swine and has potential cross-species applicability [20]. Molecular detection using polymerase chain reaction (PCR) is highly sensitive for identifying parasite DNA in feces, blood, or tissues [3, 21]. An antisense PCR assay has been developed specifically for T. gondii detection in domestic cats, improving specificity by targeting the complementary strand of the parasite's DNA [21]. PCR detection of T. gondii DNA in fecal samples from stray cats in Bangkok demonstrated the utility of molecular methods for environmental surveillance [3]. Histopathological examination of tissues, combined with immunohistochemistry, can confirm the presence of tachyzoites or tissue cysts [8, 11]. The MIC17A antigen has been evaluated as a marker for both entero-epithelial and chronic stage infections in cats [8].
Treatment and Management
Treatment of clinical toxoplasmosis in cats typically involves a combination of clindamycin (the drug of choice), pyrimethamine, and sulfonamides, often administered for several weeks [16, 17]. Supportive care, including fluid therapy, nutritional support, and management of secondary infections, is critical in severe cases. The development of gene-edited live-attenuated vaccines represents a promising avenue for preventing infection and reducing oocyst shedding in cats [16]. However, no commercial vaccine is currently available for feline use. Antiprotozoal therapy does not eliminate tissue cysts, and cats may remain latently infected for life [16, 17]. Control measures focus on reducing environmental contamination through prompt removal of feces, preventing hunting behavior, and feeding commercially processed or cooked food [5, 4, 14].
Pregnancy Guidelines and Prevention of Cat Toxoplasmosis Baby Transmission
Evidence-based guidelines for preventing congenital toxoplasmosis in households with cats are summarized in the decision tree below. The core principle is that pregnant women who are seronegative for T. gondii should avoid exposure to sporulated oocysts [12, 13, 14].
graph TD
A[Pregnant woman with cat], > B{Serological status?}
B, >|IgG+/IgM-| C[Immune. No risk of primary infection.]
B, >|IgG-/IgM-| D[Seronegative. Implement prevention.]
B, >|IgM+ or seroconversion| E[Acute infection suspected. Refer to specialist.]
D, > F[Daily litter box cleaning by another person]
D, > G[Wear gloves and wash hands if cleaning litter box]
D, > H[Keep cat indoors to prevent hunting]
D, > I[Feed cat commercial or cooked food only]
D, > J[Avoid gardening in areas accessible to cats]
D, > K[Wash fruits and vegetables thoroughly]
D, > L[Cover children's sandboxes when not in use]
F, > M[Oocysts require 1-5 days to sporulate]
M, > N[Daily removal prevents infectivity]
Seronegative pregnant women should be counseled that the risk of acquiring toxoplasmosis from a pet cat is low if basic hygiene measures are followed [14]. The cat should be kept indoors, fed only cooked or commercial food, and the litter box should be cleaned daily by a non-pregnant household member [14]. If the pregnant woman must clean the litter box, wearing disposable gloves and washing hands immediately afterward is essential [13, 14]. Gardening should be done with gloves, and all produce should be washed before consumption [13]. These measures effectively reduce the risk of cat toxoplasmosis baby transmission [12, 14].
Control and Public Health Implications
Control of T. gondii in feline populations requires a multi-pronged approach. Stray cat population management, including trap-neuter-return programs, reduces the number of free-roaming cats capable of contaminating the environment [3, 4, 6]. Public education campaigns targeting pet owners and pregnant women improve knowledge of transmission routes and prevention strategies [13, 22, 14]. In urban informal settlements, environmental degradation and social marginalization are associated with higher exposure risks, underscoring the need for targeted interventions [23, 6]. The One Health approach integrates veterinary, medical, and environmental surveillance to monitor circulating genotypes and identify emerging risk factors [17, 24]. Genotype distribution studies in animals from Bangladesh and other regions reveal diverse strain types with varying zoonotic potential [24]. Seroprevalence surveys in veterinary professionals indicate occupational exposure risks, highlighting the importance of biosecurity in clinical settings [25].
References
[1] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. https://pubmed.ncbi.nlm.nih.gov/42153709/
[2] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42020723/
[3] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42094705/
[4] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741047/
[5] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42135800/
[6] Bazan L, Argibay HD, Borges-Silva W, et al. Seroprevalence and risk factors for Toxoplasma gondii infection in wild, domestic and companion animals in urban informal settlements from Salvador, Brazil. PLoS Negl Trop Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/41401226/
[7] Didkowska A, Kołodziej-Sobocińska M, Matusik K, et al. Toxoplasma gondii in wild felides in Poland. BMC Vet Res. 2025. https://pubmed.ncbi.nlm.nih.gov/41387866/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.
[8] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41874672/
[9] Spada E, Tattarletti G, Proverbio D, et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025. https://pubmed.ncbi.nlm.nih.gov/41471183/
[10] Loeb J. Thrill seekers: how parasites change host behaviour. Vet Rec. 2026. https://pubmed.ncbi.nlm.nih.gov/41481062/
[11] Ait Issad N, Mohamed Cherif A, Mebkhout F, et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. https://pubmed.ncbi.nlm.nih.gov/41864556/
[12] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42202767/
[13] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42199683/
[14] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. https://pubmed.ncbi.nlm.nih.gov/41628830/
[15] Jesuthasan J, Merritt K, Solmi F, et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41643571/
[16] Sang X, Zhang H, Zhang Y, et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42252477/
[17] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42188907/
[18] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41965856/
[19] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42253330/
[20] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42169035/
[21] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41724116/
[22] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41873025/
[23] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42330015/
[24] Biswas PK, Aryal D, Tarak AN, et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41528989/
[25] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42201205/
[26] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42252005/
[27] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/42020619/
[28] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41931585/
[29] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/41900989/
[30] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41843222/
[31] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41819961/
[32] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L, et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741032/
[33] Murata FHA, Barboza JP, de Souza CAG, et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41651631/
[34] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP, et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. https://pubmed.ncbi.nlm.nih.gov/41603939/
[35] Filho SCC, Moron SE, Ferreira RG, et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. https://pubmed.ncbi.nlm.nih.gov/41597614/